InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Petrus Lindh. Director active across 1 company, notably Hansa Biopharma AB. In total, 1 filings have been logged. History available since 19 January 2021. The latest transaction was filed on 19 January 2021 (Purchase). Regulator: FIN-FSA. All data is free.
1 of 1 declaration